NORCELL THERAPEUTICS Trademark

Trademark Overview


On Monday, September 24, 2018, a trademark application was filed for NORCELL THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the NORCELL THERAPEUTICS trademark a serial number of 79255014. The federal status of this trademark filing is REGISTERED as of Tuesday, October 22, 2019. This trademark is owned by Nordic Nanovector AS. The NORCELL THERAPEUTICS trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations and substances, namely, pharmaceutical preparations and substances for use in hematology, oncology and for the treatment of cancer; reagents for medical use; medical diagnostic chemicals and medical diagnostic reagents for medical use; antibody-based chemicals and reagents for medical use, namely, monoclonal antibodies, immuno-radiotherapies, antibody-radionuclide-conjugates; radiotherapies in the nature of chemotherapeutics that have a similar mechanism of action; diagnostic assay test kits for medical use consisting of medical diagnostic chemicals and reagents; biochemical preparations, namely, antibodies for medical diagnostic and therapeutic use

Medical services; medical services in the field of healing, in particular diagnostic services in the field of hematology, oncology and the treatment of cancer; medical services, namely, immuno-radiotherapies and radiotherapies in the field of hematology, oncology and the treatment of cancer

Medical and pharmaceutical research and development, namely, medical and pharmaceutical research and development in the field of hematology, oncology and the treatment of cancer; conducting clinical trials for others, namely, conducting clinical trials in the field of hematology, oncology and the treatment of cancer; providing medical research and scientific research information, namely, in the field of hematology, oncology and the treatment of cancer
norcell therapeutics

General Information


Serial Number79255014
Word MarkNORCELL THERAPEUTICS
Filing DateMonday, September 24, 2018
Status700 - REGISTERED
Status DateTuesday, October 22, 2019
Registration Number5887788
Registration DateTuesday, October 22, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 6, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances, namely, pharmaceutical preparations and substances for use in hematology, oncology and for the treatment of cancer; reagents for medical use; medical diagnostic chemicals and medical diagnostic reagents for medical use; antibody-based chemicals and reagents for medical use, namely, monoclonal antibodies, immuno-radiotherapies, antibody-radionuclide-conjugates; radiotherapies in the nature of chemotherapeutics that have a similar mechanism of action; diagnostic assay test kits for medical use consisting of medical diagnostic chemicals and reagents; biochemical preparations, namely, antibodies for medical diagnostic and therapeutic use
Pseudo MarkNOR CELL THERAPEUTICS
Goods and ServicesMedical services; medical services in the field of healing, in particular diagnostic services in the field of hematology, oncology and the treatment of cancer; medical services, namely, immuno-radiotherapies and radiotherapies in the field of hematology, oncology and the treatment of cancer
Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesMedical and pharmaceutical research and development, namely, medical and pharmaceutical research and development in the field of hematology, oncology and the treatment of cancer; conducting clinical trials for others, namely, conducting clinical trials in the field of hematology, oncology and the treatment of cancer; providing medical research and scientific research information, namely, in the field of hematology, oncology and the treatment of cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 2, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 2, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 2, 2019
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNordic Nanovector AS
Party Type30 - Original Registrant
Legal Entity Type84 - NOT AVAILABLE
AddressNO

Party NameNordic Nanovector AS
Party Type20 - Owner at Publication
Legal Entity Type84 - NOT AVAILABLE
AddressNO

Party NameNordic Nanovector AS
Party Type10 - Original Applicant
Legal Entity Type84 - NOT AVAILABLE
AddressNO

Trademark Events


Event DateEvent Description
Friday, March 13, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, February 12, 2020GENERIC MADRID TRANSACTION SENT TO IB
Wednesday, February 12, 2020GENERIC MADRID TRANSACTION CREATED
Wednesday, January 22, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 22, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, August 6, 2019PUBLISHED FOR OPPOSITION
Wednesday, July 17, 2019NOTICE OF PUBLICATION
Monday, July 1, 2019ASSIGNED TO LIE
Friday, June 21, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 18, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 18, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 18, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, May 18, 2019REFUSAL PROCESSED BY IB
Monday, April 29, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, April 29, 2019REFUSAL PROCESSED BY MPU
Saturday, April 6, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, April 6, 2019APPLICATION FILING RECEIPT MAILED
Friday, April 5, 2019NON-FINAL ACTION WRITTEN
Tuesday, April 2, 2019ASSIGNED TO EXAMINER
Tuesday, April 2, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 27, 2019LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, March 21, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB